Treatment with human chorionic gonadotropin for PADAM: A preliminary report

References

• Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002; 5: 74–86
   PubMedGoogle Scholar
• Morley J E. Androgens and aging. Maturitas 2001; 38: 61–71
   PubMed Web of Science ®Google Scholar
• Morales A, Buvat J, Gooren L J, Guay A T, Kaufman J -M, Tan H M, Torres L O. Endocrine aspects of sexual dysfunction in men. J Sex Med 2004; 1: 69–81
   PubMed Web of Science ®Google Scholar
• Morley J E, Perry H M, III. Androgen deficiency in aging men. Med Clin North Am 1999; 83: 1279–1289
   PubMed Web of Science ®Google Scholar
• Vermeulen A. Andropause. Maturitas 2000; 34: 5–15
   PubMed Web of Science ®Google Scholar
• Morales A, Heaton J P, Carson C C, III. Andropause: a misnomer for a true clinical entity. J Urol 2000; 163: 705–712
   PubMed Web of Science ®Google Scholar
• Morley J E. Testosterone replacement and the physiologic aspects of aging in men. Mayo Clin Proc 2000; 75(Suppl)S83–S87
   PubMedGoogle Scholar
• Morley J E. Testosterone replacement in older men and women. J Gend Specif Med 2001; 4: 49–53
   PubMedGoogle Scholar
• Morley J E, Perry H M, III. Androgen treatment of male hypogonadism in older males. J Steroid Biochem Mol Biol 2003; 85: 367–373
   PubMed Web of Science ®Google Scholar
• Comhaire F H. Andropause: hormone replacement therapy in the ageing male. Eur Urol 2000; 38: 655–662
   PubMed Web of Science ®Google Scholar
• Morales A, Johnston B, Heaton J P, Lundie M. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol 1997; 157: 849–854
   PubMed Web of Science ®Google Scholar
• Dobs A S, Meikle A W, Arver S, Sanders S W, Caramelli K E, Mazer N A. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999; 84: 3469–3478
   PubMed Web of Science ®Google Scholar
• Veldhuis J D, Iranmanesh A, Godschalk M, Mulligan T. Older men manifest multifold synchrony disruption of reproductive neurohormone outflow. J Clin Endocrinol Metab 2000; 85: 1477–1486
   PubMed Web of Science ®Google Scholar
• Veldhuis J D, Urban R J, Lizarralde G, Johnson M L, Iranmanesh A. Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 1992; 75: 707–713
   PubMed Web of Science ®Google Scholar
• Veldhuis J D, Zwart A, Mulligan T, Iranmanesh A. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men. J Clin Endocrinol Metab 2001; 86: 529–535
   PubMed Web of Science ®Google Scholar
• Finkel D M, Phillips J L, Snyder P J. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985; 313: 651–655
   PubMed Web of Science ®Google Scholar
• Liu P Y, Gebski V J, Turner L, Conway A J, Wishart S M, Handelsman D J. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 2002; 17: 625–633
   PubMed Web of Science ®Google Scholar
• Amelar R D, Dubin L. Human chorionic gonadotrophin therapy in male infertility. JAMA 1977; 237: 2423
   PubMed Web of Science ®Google Scholar
• Schill W B, Jungst D, Unterburger P, Braun S. Combined hMG/hCG treatment in subfertile men with idiopathic normogonadotrophic oligozoospermia. Int J Androl 1982; 5: 467–477
   PubMedGoogle Scholar
• Heinemann L A, Zimmermann T, Vermeulen A, Thiel C. A new ‘aging males’ symptoms' (AMS) rating scale. Aging Male 1999; 2: 105–114
   Google Scholar
• Rosen R C, Riley A, Wagner G, Osterloh I H, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830
   PubMed Web of Science ®Google Scholar
• Zung W W, Richards C B, Short M J. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13: 508–515
   PubMed Web of Science ®Google Scholar
• Snyder P J, Peachey H, Hannoush P, Berlin J A, Loh L, Lenrow D A, Holmes J H, Dlewati A, Santanna J, Rosen C J, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 2647–2653
   PubMed Web of Science ®Google Scholar
• Snyder P J, Peachey H, Hannoush P, Berlin J A, Loh L, Holmes J H, Dlewati A, Staley J, Santanna J, Kapoor S C, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966–1972
   PubMed Web of Science ®Google Scholar
• Ferrando A A, Sheffield-Moore M, Yeckel C W, Gilkison C, Jiang J, Achacosa A, Lieberman S A, Tipton K, Wolfe R R, Urban R J. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002; 282: E601–E607
   PubMed Web of Science ®Google Scholar
• Rabkin J G, Wagner G J, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000; 57: 141–147, discussion 155–156.
   PubMed Web of Science ®Google Scholar
• Hajjar R R, Kaiser F E, Morley J E. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997; 82: 3793–3796
   PubMed Web of Science ®Google Scholar
• Kunelius P, Lukkarinen O, Hannuksela M L, Itkonen O, Tapanainen J S. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab 2002; 87: 1467–1472
   PubMed Web of Science ®Google Scholar
• Morley J E, Tariq S H. Sexuality and disease. Clin Geriatr Med 2003; 19: 563–573
   PubMed Web of Science ®Google Scholar
• Namiki M, Kitamura M, Miyake O, Nakamura M, Okuyama A, Sonoda T, Takeyama M, Fujioka H, Matsumoto K. Reduction of testicular human chorionic gonadotropin receptors by human chorionic gonadotropin in infertile men. Arch Androl 1988; 20: 45–50
   PubMed Web of Science ®Google Scholar
• Tsujimura A, Matsumiya K, Matsuoka Y, Takahashi T, Koga M, Iwasa A, Takeyama M, Okuyama A. Bioavailable testosterone with age and erectile dysfunction. J Urol 2003; 170: 2345–2347
   PubMed Web of Science ®Google Scholar
• Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34(Suppl 1)S9–S16
   PubMed Web of Science ®Google Scholar
• Tenover J S. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092–1098
   PubMed Web of Science ®Google Scholar
• Liu P Y, Wishart S M, Handelsman D J. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab 2002; 87: 3125–3135
   PubMed Web of Science ®Google Scholar
• T'Sjoen G, Goemaere S, De Meyere M, Kaufman J M. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004; 29: 201–214
   PubMed Web of Science ®Google Scholar
• T'Sjoen G, Feyen E, De Kuyper P, Comhaire F, Kaufman J M. Self-referred patients in an aging male clinic: much more than androgen deficiency alone. Aging Male 2003; 6: 157–165
   PubMedGoogle Scholar
• Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S, Koga M, Iwasa A, Takeyama M, Okuyama A. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Imp Res 2005; 17: 259–263
   PubMed Web of Science ®Google Scholar